Elevated FFAs not only inhibit the eNOS/NO signal pathway and decrease NO production, but also activate NADPH oxidase, increase production of O2−, and reduce NO bioactivity during the development of atherosclerosis and thrombosis in vascular complications associated with obesity and diabetes. The gene discussed is FMO5; the disease is diabetes mellitus.